These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10831322)
1. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. Lang S; Atarashi Y; Nishioka Y; Stanson J; Meidenbauer N; Whiteside TL Cell Immunol; 2000 May; 201(2):132-43. PubMed ID: 10831322 [TBL] [Abstract][Full Text] [Related]
2. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320 [TBL] [Abstract][Full Text] [Related]
3. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. Daniel PT; Kroidl A; Cayeux S; Bargou R; Blankenstein T; Dörken B J Immunol; 1997 Oct; 159(8):3808-15. PubMed ID: 9378968 [TBL] [Abstract][Full Text] [Related]
4. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor. Chan AK; Goedegebuure PS; von Bernstorff W; Carritte AL; Chung M; Stewart RA; Montgomery L; Spanjaard RA; McKenzie AB; Eberlein TJ Surgery; 2000 Mar; 127(3):342-50. PubMed ID: 10715992 [TBL] [Abstract][Full Text] [Related]
5. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916 [TBL] [Abstract][Full Text] [Related]
6. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681 [TBL] [Abstract][Full Text] [Related]
7. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017 [TBL] [Abstract][Full Text] [Related]
8. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876 [TBL] [Abstract][Full Text] [Related]
10. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824 [TBL] [Abstract][Full Text] [Related]
11. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein. Blanco B; Holliger P; Alvarez-Vallina L Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444 [TBL] [Abstract][Full Text] [Related]
12. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. Gajewski TF; Renauld JC; Van Pel A; Boon T J Immunol; 1995 Jun; 154(11):5637-48. PubMed ID: 7538528 [TBL] [Abstract][Full Text] [Related]
13. Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade. Gastman BR; Yin XM; Johnson DE; Wieckowski E; Wang GQ; Watkins SC; Rabinowich H Cancer Res; 2000 Dec; 60(24):6811-7. PubMed ID: 11156370 [TBL] [Abstract][Full Text] [Related]
14. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939 [TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins. Holliger P; Manzke O; Span M; Hawkins R; Fleischmann B; Qinghua L; Wolf J; Diehl V; Cochet O; Winter G; Bohlen H Cancer Res; 1999 Jun; 59(12):2909-16. PubMed ID: 10383154 [TBL] [Abstract][Full Text] [Related]
17. Fas involvement in cytotoxicity mediated by human NK cells. Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525 [TBL] [Abstract][Full Text] [Related]
18. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells. Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845 [TBL] [Abstract][Full Text] [Related]
19. Concurrent induction of T-cell activation and apoptosis of osteosarcoma cells by adenovirus-mediated B7-1/Fas chimeric gene transfer. Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yagita H; Okumura K; Yamashita T; Uede T Cancer Gene Ther; 2003 Sep; 10(9):717-25. PubMed ID: 12944991 [TBL] [Abstract][Full Text] [Related]
20. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis. Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]